Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: Possible associations with cytochrome P450 metabolism and increased protein tyrosine phosphorylation

Toxicology and Applied Pharmacology

Volumn 149, Issue 1, 1998, Pages 80-89

  Mounho, Barbara J ^a,b   Burchiel, Scott W ^b  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cytochrome P450; Human B cells; Immunotoxicity; Intracellular Ca2+; Polycyclic aromatic hydrocarbons; Protein tyrosine kinases; Signal transduction

Indexed keywords

7,8 DIHYDRO 7,8 DIHYDROXYBENZO[A]PYRENE; 7,8 DIHYDROXYBENZO[A]PYRENE 9,10 OXIDE; ALPHA NAPHTHOFLAVONE; BENZO[E]PYRENE; CYTOCHROME P450; DRUG METABOLITE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; B LYMPHOCYTE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DAUDI CELL; DRUG COMPARISON; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOTOXICITY; IN VITRO STUDY; MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PHOSPHORYLATION;

EID: 0031906802     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8345     Document Type: Article

References (80)

1. Alberola-Ila, J., Takaki, S., Kerner, J. D., and Perlmutter, R. M. (1997). Differential signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 15, 125-154.
2. Archuleta, M. M., Schieven, G. L., Ledbetter, J. A., Deanin, G. G., and Burchiel, S. W. (1993). 7,12-dimethylbenz(a)anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T cell line and increases tyrosine phosphorylation of phospholipase C-yl, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA. 90, 6105-6109.
3. Bast, R. C., Whitlock, J. P., Miller, H., Rapp, H. J., and Gelboin, H. V. (1974). Aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes. Nature 250, 664-665.
4. Bauer, E., Guo, Z., Ueng, Y., Bell, L. C., Zeldin, D., and Guengerich, F. P. (1995). Oxidation of benzo(a)pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8, 136-142.
5. Blank, J. A., Tucker, A. N., Sweatlock, J., Gasiewicz, T. A., and Luster, M. I. (1987). α-Naphtho-flavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression. Mol. Pharmacol. 32, 168-172.
6. Bolen, J. B., and Brugge, J. S. (1997). Leuokocyte protein tyrosine kinases: Potential targets for drug development. Annu. Rev. Immunol. 15, 371-404.
7. ++ channels in human B lymphocytes. J. Cell. Physiol. 155, 520-529.
8. Burchiel, S. W., Davis, D. P., Ray, S. D., and Barton, S. L. (1993). DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma. Fundam. Appl. Toxicol. 21, 120-124.
9. Burchiel, S. W., Thompson, T. A., and Davis, D. P. (1991). Alterations in mitogen-induced calcium mobilization and intracellular free calcium produced by 7,12-dimethylbenz(a)anthracene (DMBA) in the Jurkat human T cell line. Int. J. Immunopharmacol. 13, 109-115.
10. Carter, R. H., Park, D. J., Rhee, S. G., and Fearon, D. T. (1991). Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes. Proc Natl. Acad. Sci. USA 88, 2745-2749.
11. Coggeshall, K. M., McHugh, J. C., and Altman, A. (1992). Predominant expression and activation-induced tyrosine phosphorylation of phospholipase C-γ2 in B lymphocytes. Proc. Natl. Acad. Sci. USA 89, 5660-5664.
12. Conney, A. H., Chang, R. L., Jerina, D. M., and Wei, S.-J. C. (1994). Studies on the metabolism of benzo(a)pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 26, 125-163.
13. 2+-associated signaling pathways in the immunotoxicity of polycyclic aromatic hydrocarbons. J. Toxicol. Environ. Health 44, 101-126.
14. Davila, D. R., Romero, D. L., and Burchiel, S. W. (1996). Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by α-naphthoflavone. Toxicol. Appl. Pharmacol. 139, 333-341.
15. Davis, D. P., and Burchiel, S. W. (1992). Inhibition of calcium-dependent pathways of B cell activation by DMBA. Toxicol. Appl. Pharmacol. 116, 202-208.
16. Dean, J. H., Luster, M. I., Boorman, G. A., Lauer, L. D., Leubke, R. W., and Lawson, L. (1983). Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice. Clin. Exp. Immunol. 52, 199-206.
17. Dipple, A. (1994). Reactions of polycyclic aromatic hydrocarbons with DNA. IARC Sci. Publ. 125, 107-129.
18. El-Hillal, O., Kurosaki, T., Yamamura, H., Kinet, J.-P., and Scharenberg, A. M. (1997). Syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc. Natl. Acad. Sci. USA 94, 1919-1924.
19. Erpel, T., and Courtneidge, S. A. (1995). Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7, 176-182.
20. Gasiewicz, T. A., and Rucci, G. (1991). α-Naphthoflavone acts as an antagonist of 2,3,7,8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol. Pharmacol. 40, 607-612.
21. Gelboin, H. V. (1980). Benzo(a)pyrene metabolism, activation, and carcinogenesis: Role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60, 1107-1166.
22. Goujon, F. M., Nebert, D. W., and Gielen, J. E. (1972). Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P450 and the effect on benzo(a)pyrene metabolism in vitro. Mol. Pharmacol. 8, 667-680.
23. Gupta, R. C., Early, K., and Sharma, S. (1988). Use of human peripheral blood lymphocytes to measure DNA binding capacity of chemical carcinogens. Proc. Natl. Acad. Sci. USA 85, 3513-3517.
24. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
25. Hardin, J. A., Hisnoshit, F., and Sherr, D. H. (1992). Mechanisms by which benzo(a)pyrene, an environmental carcinogen, suppress B cell lymphopoiesis. Toxicol. Appl. Pharmacol. 117, 155-164.
26. ras1. J. Immunol. 151, 4513-4522.
27. Holsapple, M. P., Karras, J. G., Putney, J. W., Ledbetter, J. A., Schieven, G. L., Burchiel, S. W., Burchiel, Davila, D. R., Schatz, A. R., and Kaminski, N. E. (1996). Molecular mechanisms of toxicant-induced immunosuppression: Role of second messengers. Annu. Rev. Pharmacol. Toxicol. 36, 131-159.
28. Johnson, S. A., Pleiman, C. M., Pao, L., Schneringer, J., Hippen, K., and Cambier, J. C. (1995). Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases. J. Immunol. 155, 4596-4603.
29. Justement, L. B., Brown, V. K., and Lin, J. (1994). Regulation of B-cell activation of CD45: A question of mechanism. Immunol. Today 15, 399-406.
30. Kawabata, T. T., and White, K. L. (1987). Suppression of the in vitro humoral immune response of mouse splenocytes by benzo(a)pyrene metabolites and inhibition of benzo(a)pyrene-induced immunosuppression by α-naphthoflavone. Cancer Res. 47, 2317-2322.
31. Klein, E., Klein, G., Nadkarni, J. S., Nadkarni, J. J., Wigzell, H., and Clifford, P. (1968). Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture cells. Cancer Res. 28, 1300-1310.
32. Krejsa, C. M., Nadler, S. G., Esselstyn, J. M., Kavanagh, T. J., Ledbetter, J. A., and Schieven, G. L. (1997). Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. J. Biol. Chem. 272, 11541-11549.
33. Kress, S., and Greenlee, W. F. (1997). Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57, 1264-1269.
34. Krieger, J. A., Born, J. L., and Burchiel, S. W. (1994). Persistence of calcium elevation in the HPB-ALL human T cell line correlates with immunosuppressive properties of polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 127, 268-274.
35. Krieger, J. A., Davila, D. R., Lytton, J., Born, J. L., and Burchiel, S. W. (1995). Inhibition of sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human T cells and other tissues. Toxicol. Appl. Pharmacol. 133, 102-108.
36. Kurosaki, T., Johnson, S. A., Pao, L., Sada, K., Yamamura, H., and Cambier, J. C. (1995). Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J. Exp. Med. 182, 1815-1833.
37. Kuwahara, K., Igarashi, H., Kawai, T., Yasuhisa, I., Muraguchi, A., Mason, D., Kimoto, M., Inui, S., and Sakaguchi, N. (1993). Induction of tyrosine phosphorylation in human B lineage cells by crosslinking MB-1 molecule of B cell receptor-related heterodimer complex. Biochem. Biophys. Res. Commun. 3, 1563-1569.
38. Ladies, G. S., Kawabata, T. T., Munson, A. E., and White, K. L. (1992a). Metabolism of benzo(a)pyrene by murine splenic cell types. Toxicol. Appl. Pharmacol. 116, 248-257.
39. Ladies, G. S., Kawabata, T. T., Munson, A. E., and White, K. L. (1992b). Evaluation of murine splenic cell type metabolism of benzo(a)pyrene and functionality in vitro following repeated in vivo exposure to benzo(a)pyrene. Toxicol. Appl. Pharmacol. 116, 258-266.
40. Ladies, G. S., Kawabata, T. T., and White, K. L. (1991). Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz(a)anthracene metabolites and inhibition of immunosuppression by α-naphthoflavone. Toxicol. Appl. Pharmacol. 110, 31-44.
41. Luster, M. I., Portier, C., Pait, D. G., White, K. L., Gennings, C., Munson, A. E., and Rosenthal, G. J. (1992). Risk assessment in Toxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18, 200-210.
42. Matsumura, R., Enan, E., and Olsen, H. (1993). 2,3,7,8-tetrachlorodibenzo(p)dioxin (TCDD) alters pancreatic membrane tyrosine phosphorylation following acute treatment. J. Biochem. Toxicol. 8, 71-81.
43. Merchant, M., Arellano, L., and Safe, S. (1990). The mechanisms of action a α-naphthoflavone as a inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin induced CYP1A1 gene expression. Arch. Biochem. Biophys. 281, 84-89.
44. Merchant, M., Krishnan, V., and Safe, S. (1993). Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol. Appl. Pharmacol. 120, 179-185.
45. Miller, J. A. (1970). Carcinogenesis by chemicals: An overview. Clowes Memorial Lecture. Cancer Res. 30, 559-571.
46. Mounho, B. J., Davila, D. R., and Burchiel, S. W. (1997). Characterization of intracellular calcium responses produced by polycyclic aromatic hydrocarbons in surface marker-defined human peripheral blood mononuclear cells. Toxicol. Appl. Pharmacol. 145, 323-330.
47. Mounho, B., Davila, D. R., Lauer, F., Puga, A., Gil, C. M., and Burchiel, S. W. (1996). Evaluation of the potential role of aromatic hydrocarbon (Ah) receptors in calcium signaling by polycyclic aromatic hydrocarbons (PAHs) in human T cells. Toxicologist 30, 321. [Abstract]
48. 1 phase of the cell cycle. Toxicol. Appl. Pharmacol. 119, 166-174.
49. Nebert, D. W. (1989). The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20, 153-174.
50. Novak, E. J., and Rabinovitch, P. S. (1994). Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3/fura red fluorescence ratios. Cytometry 17, 135-141.
51. Okano, P., Miller, H. N., Robinson, R. C., and Gelboin, H. V. (1979). Comparison of benzo(a)-pyrene and (-)-trans-7,8-dihydroxydihydrobenzo(a)pyrene metabolism in human blood monocytes and lymphocytes. Cancer Res. 39, 3184-3193.
52. Okey, A. B., Dube, A. W., and Vella, L. M. (1984). Binding of benzo(a)pyrene and dibenz(a,h)-anthracene to the Ah receptor in mouse and rat hepatic cytosols. Cancer Res. 44, 1426-1432.
53. Panayotou, G., and Waterfield, M. D. (1993). The assembly of signalling complexes by receptor tyrosine kinases. BioEssays 15, 171-177.
54. Pliszczynska, P., Keys, B., Safe, S., and Newman, M. S. (1986). The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol. Lett. 34, 67-74.
55. lyn regulates calcium mobilization in chicken B cell oxidant stress signaling. Eur. J. Biochem. 236, 443-449.
56. Reth, M., and Wienands, J. (1997). Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15, 453-479.
57. Romero, D. L., Mounho, B. J., Born, J. L., and Burchiel, S. W. (1997). Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol esters in human peripheral blood mononuclear cells. Toxicol. Appl. Pharmacol. 144, 62-69.
58. Santostefano, M., Merchant, M., Arellano, L., Morrison, V., Denison, M. S., and Safe, S. (1992). α-Naphthoflavone-induced CYP1A1 expression and cytosolic aryl hydrocarbon receptor transformation. Mol. Pharmacol. 43, 200-206.
59. 2+ signals. J. Biol. Chem. 268, 16688-16692.
60. 2-induced T cell signal transduction. J. Biol. Chem. 269, 20718-20726.
61. Schmidt, J. V., and Bradfield, C. A. (1996). Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
62. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, P., and Sutter, T. R. (1996). Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56, 2979-2984.
63. Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F. P. (1989). Roles of individual human cytochrome P450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydro-benzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49, 6304-6312.
64. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. (1994). Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414-423.
65. Staal, F. J. T., Anderson, M. T., Staal, G. E. J., Herzenberg, L. A., Gitler, C., and Herzenberg, L. A. (1994). Redox regulation of signal transduction: Tyrosine phosphorylation and calcium flux. Proc. Natl. Acad. Sci. USA 91, 3619-3622.
66. Suzuki, Y., Ohsugi, K., and Ono, Y. (1996). Oxidative stress triggers tyrosine phosphorylation in B cells through redox- and inflammatory cytokine-sensitive mechanism. Immunology 87, 396-401.
67. Thakker, D. R., Yagi, H., Akagi, H., Koreeda, M., Lu, A., Levin, W., Wood, A. W., Conney, A. H., and Jerina, D. M. (1977). Metabolism of benzo(a)pyrene. VI. Stereoselective metabolism of benzo(a)pyrene 7,8-dihydrodiol to diol epoxides. Chem.-Biol. Interact. 16, 281-300.
68. Thurmond, L. M., House, R. V., Lauer, L. D., and Dean, J. H. (1988). Suppression of splenic lymphocyte function by 7,12-dimethylbenz(a)anthracene (DMBA) in vitro. Toxicol. Appl. Pharmacol. 93, 369-377.
69. Tseng, J., Lee, Y. J., Eisfelder, B. J., and Marcus, C. R. (1994). The B cell antigen receptor complex: Mechanisms and implications of tyrosine kinase activation. Immunol. Res. 13, 299-310.
70. 3-450 genes. Dev. Biol. 112, 177-184.
71. Uehara, Y., Hori, M., Takeuchi, T., and Umezawa, H. (1986). Phenotypic change from normal to transformed induced by benzoquinoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol. Cell. Biol. 6, 2198-2206.
72. Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
73. van Oers, N., and Weiss, A. (1995). The Syk/Zap-7-protein tyrosine kinase connection to antigen receptor signalling processes. Immunology 7, 227-236.
74. Waithe, W. I., Michaud, M., Harper, P. A., Okey, A. B., and Anderson, A. (1991). The Ah receptor, cytochrome P4501A1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem. Pharmacol. 41, 85-92.
75. Weiss, A., and Littman, D. R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
76. White, K. L., Jr., and Holsapple, M. P. (1984). Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not the noncarcinogenic congener benzo(e)pyrene. Cancer Res. 44, 3388-3393.
77. White, K. L., Kawabata, T. T., and Ladies, G. S. (1994). Mechanisms of polycyclic aromatic hydrocarbon immunotoxicity. In Immunotoxicology and Immunopharmacology, 2nd ed. (J. H. Dean, M. I. Luster, A. E. Munson, and I. Kimber, Eds.), pp. 123-142. Raven Press, New York.
78. Whitlock, J. P., Cooper, H. L., and Gelboin, H. V. (1972). Aryl hydrocarbon (benzopyrene) hydroxylase is stimulated in human lymphocytes by mitogens and benz(a)anthracene. Science 177, 618-619.
79. Wilhelmsson, A., Whitelaw, M. L., Gustafsson, J.-A., and Poellinger, L. (1994). Agonistic and antagonistic effects of α-naphthoflavone on dioxin receptor function. J. Biol. Chem. 269, 19028-19033.
80. Yamanashi, Y., Yasuhisa, F., Wongsasant, B., Yumiko, K., Yuzo, I., Kumao, T., and Yamamoto, T. (1992). Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA 89, 1118-1122.